相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antifungal use in hospitalized adults in US academic health centers
Amy L. Pakyz et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2011)
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Olivier Lortholary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy
Sofia Costa-de-Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Candidemia in the intensive care unit: Miles to go before we sleep
Peter G. Pappas
CRITICAL CARE MEDICINE (2011)
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2011)
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)
Michael A. Pfaller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei
Andrew F. Shorr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis
Chin Fen Neoh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin
M. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
National Surveillance of Fungemia in Denmark (2004 to 2009)
Maiken Cavling Arendrup et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Echinocandin-Resistant Candida: Molecular Methods and Phenotypes
David S. Perlin
CURRENT FUNGAL INFECTION REPORTS (2011)
Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections
Cassandra Moran et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2010)
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections
Ingi Lee et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2010)
Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: Potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance
Ingi Lee et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2010)
Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient
Florence Chapeland-Leclerc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Changing trends in the epidemiology of Candida blood stream infections: A matter for concern?
J. D. Sobel
CRITICAL CARE MEDICINE (2010)
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients
Yves Cohen et al.
CRITICAL CARE MEDICINE (2010)
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida Time for harmonization of CLSI and EUCAST broth microdilution methods
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2010)
Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review
Hsin-Yun Sun et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Caspofungin-non-susceptible Candida isolates in cancer patients
Diamantis P. Kofteridis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients
Donald I. Hsu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
David A. Oxman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice
Sheenu Chandwani et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
Michael J. Klevay et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Fungal Infections in the ICU
Marya D. Zilberberg et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during Candidemia treatment
John D. Cleary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Changing epidemiology of invasive candidiasis in intensive care units - Much ado about nothing?
Jack D. Sobel
CRITICAL CARE MEDICINE (2008)
Risk factors for albicans and non-albicans candidemia in the intensive care unit
Jennifer K. Chow et al.
CRITICAL CARE MEDICINE (2008)
Candidemia in nonneutropenic critically ill patients:: Risk factors for non-albicans Candida spp.
E. Geoffrey Playford et al.
CRITICAL CARE MEDICINE (2008)
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Bench-to-bedside review: Candida infections in the intensive care unit
Marie Mean et al.
CRITICAL CARE (2008)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia
Andrew F. Shorr et al.
CRITICAL CARE MEDICINE (2007)
Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes
Brunella Posteraro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility
K Niimi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient
M Krogh-Madsen et al.
CLINICAL INFECTIOUS DISEASES (2006)
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
SA Messer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Surgical critical care: Fungal infections in surgical patients
Pamela A. Lipsett
CRITICAL CARE MEDICINE (2006)
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
